HIBERIX
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE 10 MCG / 0.5 ML
Available from:
GLAXO SMITH KLINE (ISRAEL) LTD
ATC code:
J07AG01
Pharmaceutical form:
POWDER FOR SOLUTION FOR INJECTION
Administration route:
I.M
Manufactured by:
GLAXO SMITH KLINE BIOLOGICALS S.A
Therapeutic group:
HEMOPHILUS INFLUENZAE B, PURIFIED ANTIGEN CONJUGATED
Therapeutic indications:
Active immunisation for all infants from the age of two months against disease caused by Hib
Authorization date:
2009-02-01
